BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33638929)

  • 41. A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma.
    Serenari M; Han KH; Ravaioli F; Kim SU; Cucchetti A; Han DH; Odaldi F; Ravaioli M; Festi D; Pinna AD; Cescon M
    J Hepatol; 2020 Oct; 73(4):855-862. PubMed ID: 32360997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.
    He YF; Jin J; Wei W; Chang Y; Hu B; Ji CS; Jia WD; Wang XQ; Chen K; Chen J
    Can J Gastroenterol; 2010 Jul; 24(7):435-40. PubMed ID: 20652159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma.
    Wang YY; Xiang BD; Ma L; Zhong JH; Ye JZ; Wang K; Xing BC; Li LQ
    Ann Surg; 2021 Dec; 274(6):e1209-e1217. PubMed ID: 32097166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.
    Kaibori M; Kubo S; Nagano H; Hayashi M; Haji S; Nakai T; Ishizaki M; Matsui K; Uenishi T; Takemura S; Wada H; Marubashi S; Komeda K; Hirokawa F; Nakata Y; Uchiyama K; Kwon AH
    World J Surg; 2013 Apr; 37(4):820-8. PubMed ID: 23340708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of margin status on long-term results of liver resection for hepatocellular carcinoma: single-center time-to-recurrence analysis.
    Gruttadauria S; Pagano D; Corsini LR; Cintorino D; Li Petri S; Calamia S; Seidita A; di Francesco F
    Updates Surg; 2020 Mar; 72(1):109-117. PubMed ID: 31625024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.
    Liao R; Fu YP; Wang T; Deng ZG; Li DW; Fan J; Zhou J; Feng GS; Qiu SJ; Du CY
    Oncotarget; 2017 Jan; 8(1):1774-1787. PubMed ID: 27662665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
    Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
    World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
    Ma KW; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM; Chok KSH
    Surg Today; 2019 Jun; 49(6):521-528. PubMed ID: 30637484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.